Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2025-04-07 Regulatory Filings
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 60% confidence The document is a corporate press release announcing an upcoming medical symposium, including event details, speakers, and registration instructions. It does not contain financial results, management changes, dividends, regulatory filings like annual or interim reports, or other specific filings. It is a general corporate announcement and does not fit any specialized category, so it falls under the fallback category of Regulatory Filings (RNS).
2025-04-07 English
Material change report - English.pdf
Regulatory Filings
2025-04-04 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing the company’s inability to timely file its audited consolidated financial statements and MD&A, and application for a Management Cease Trade Order under Canadian securities rules. It does not present financial results (so it’s not an Earnings Release or Annual/Interim Report), nor is it an attachment of a report. It is a regulatory announcement fulfilling disclosure obligations. This falls under the generic Regulatory Filings category (RNS).
2025-04-01 English
News release - English.pdf
Report Publication Announcement Classification · 88% confidence The document is a press release announcing the timing of the company’s full‐year 2024 earnings release (to be filed March 31, 2025) and inviting investors to a conference call on April 1, 2025. It contains no financial results itself but rather announces when the report will be published and how to access the call. This fits the definition of a Report Publication Announcement (RPA).
2025-03-18 English
News release - English.pdf
Regulatory Filings
2025-01-16 English
News release - English.pdf
Regulatory Filings Classification · 50% confidence The document is a press release announcing the completion of the first product delivery under a commercial supply agreement. It is not a financial report, earnings release, or regulatory form; it does not announce financing, share issues, or management changes. There is no indication of AGM materials or voting results. It is a general corporate announcement, best classified under the fallback category Regulatory Filings (RNS).
2024-12-02 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.